Presentation is loading. Please wait.

Presentation is loading. Please wait.

Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy.

Similar presentations


Presentation on theme: "Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy."— Presentation transcript:

1 Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy

2 Application Filings and and Examiner Production Examiner Production

3 3 UPR Applications Filed   FY 05 plan 375,080 (5.5% above FY 04)   FY 05 actual 384,228 (8.1% above FY04)   2.6% over plan

4 4 FY 04 FY 05 Target FY 05 UPR 1 FAOM 2 288,315297,614297,287 UPR Disposals 3 287,188295,456279,345 UPR Production Units 4 287,752296,535288,316 PCT Production Units 5 16,88222,91615,147 Production 1 “ UPR” = Utility, Plant, and Reissue Applications. 2 “ FAOM” = First Action on the Merits – first action count by an examiner after the filing of an application (does not include restrictions or other miscellaneous actions). 3 “ Disposal” = An examiner allowance, abandonment, or disposals following a board decision. 4 “ Production Unit” = First action count plus disposal count divided by 2. 5 “ PCT” = Patent Cooperation Treaty. PCT applications are processed differently and tracked separately from US National stage applications. For FY 05, 15,147 PU’s is 35,389 processed applications.

5 ... vs the Backlog PENDENCY

6 6 Patent Pendency (as of 1/1/2006) Patent Pendency (as of 1/1/2006) Technology Center Average 1 st Action Pendency (months) 1 Average Total Pendency (months) 2 1600 - Biotechnology and Organic Chemistry23.3 33.5 1700 - Chemical and Materials Engineering 20.6 29.8 2100 - Computer Architecture Software and Information Security 33.1 44.8 2600 – Communications31.243.9 2800 - Semiconductor, Electrical, Optical Systems15.025.0 3600 - Transportation, Construction, Electronic Commerce19.8 27.5 3700 - Mechanical Engineering, Manufacturing and Products18.626.6 UPR Total (as of 10/1/2005) 21.830.6 1 “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during October-December 2005. 2 “Average total pendency” is the average age from filing to issue or abandonment of a newly filed application, completed during October-December 2005.

7 7 First Action Pendency by Art Areas High Pendency Art Areas Pendency 1 (months) Low Pendency Art Areas Pendency 1 (months) 1640 – Immunology, Receptor/ Ligands, Cytokines, Recombinant Hormones, and Molecular Biology 27.7 1620 – Heterocyclic Compounds and Uses 16.9 1743 – Analytic Chemistry & Wave Energy 30.81752 – Radiation Imagery12.1 2123 – Simulation and Modeling, Emulation of Computer Components 39.7 2125 – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control 20.0 2617 – Interactive Video Distribution50.4 2651 – Dynamic Information Storage & Retrieval 16.1 2836 – Control Circuits24.32833 – Electrical Connectors8.8 3628 – Finance & Banking, Accounting52.13612 – Land Vehicles12.0 3731 – Surgery: Cutting, Clamping, Suturing 30.93723 – Tools & Metal Working10.9 1 “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during October-December 2005.

8 8 Inventory by Art Examples High Inventory Art Areas Months of Inventory* Low Inventory Art Areas Months of Inventory* 1614, 1615, and 1617 – Drugs, Bio-affecting and Body Treatment 38-511620 – Organic Chemistry15 1753 – Radiation Imagery34 1734 – Adhesive Bonding and Coating Apparatus 10 2127 – Computer Task Management46 2125 – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control 10 2611 – Interactive Video Distribution114 2651, 2653 – Information Storage and Retrieval 12 2836 – Control Circuits222831 – Electrical Conductors8 3620 – Business Methods22-1363651 – Conveying12 3731 and 3737 – Medical Instruments, Diagnostic Equipment 38-47 3742 – Thermal and Combustion Technology 8 * The number of months it would take to reach a first action on the merits (e.g., an action addressing patentability issues) on a new application filed in July 2005 at today’s production rate. Today’s production rate means that there are no changes in production due to hiring, attrition, changes to examination processing or examination efficiencies, and that applications are taken up in the order of filing in the given art unit/area. Of course, USPTO is taking aggressive steps to ensure changes that will significantly lower the inventory rates in high-inventory art areas.

9 9 1600170021002600280036003700Total*Design New Applications 1 9/30/2004 55,40263,92371,77897,38077,65156,73865,005508,87818,451 New Applications 1 9/30/2005 62,64472,69776,529115,58594,42570,35483,225586,58024,534 Overall Pending Applications 2 9/30/2004 95,006105,447102,440138,822137,458101,097108,039809,32327,599 Overall Pending Applications 2 9/30/2005 107,647120,767117,728167,721159,687117,045130,168932,30038,104 TC Application Inventory 1 “ New Application inventory” is the number of new applications designated or assigned to a technology center awaiting a first action. 2 “ Overall Pending Application inventory” is the total number of applications designated or assigned to a technology center in an active status. Includes new applications; rejected awaiting response; amended; under appeal or interference; suspended; reexams and allowed applications awaiting grant publication. *Total inventory includes applications not assigned to a particular TC, awaiting processing either pre- or post-examination.

10 Patent Quality (Shared Responsibility)

11 11 Quality of Products – FY 05 Fiscal Year 2005 FY 041600170021002600280036003700 Desig n FY 05 FY 05 Target Patent In-Process Examination Compliance Rate 1* 82.0%81.7%82.9%88.1%84.7%90.9%84.4%86.6%94.3%86.2%84.0% Patent Allowance Error Rate 2* 5.32%4.88%6.46%3.56%2.25%4.43%4.94%6.43%1.6%4.55%4.0% *Compliance and error rates as measured by OPQA. 1 Compliance is the percent of office actions reviewed and found to be free of any in-process examination deficiency (an error that has significant adverse impact on patent prosecution). 2 Patent allowance error rate is the percent of allowed applications reviewed having at least one claim which is considered unpatentable on a basis for which a court would hold a patent invalid. “Allowance” occurs before a patent is issued, so these errors are caught before any patent is actually granted.

12 Re-Work

13 13 Technology Centers Rework* Statistics * Rework first actions are those actions that are in a Continuing (CONs and CIPs), RCE, CPA or 129(a) applications (excludes Divisionals).

14 Hiring and Retention

15 15 Hires and Attritions 1600170021002600280036003700CorpsDesign FY 04 Hires753511511631264544315 FY 04 Attritions302658825843393364 FY 05 BOY Examiner Staff 417440563658742422439368172 FY 05 Hiring (10/1/05)101582251691849113195919 FY 05 Attrits (10/1/05)4239939254555042510 FY 05 Hiring Goal100352001501609012586020 New Hires as a Percent of Examiner Staffing in the TC 24%13%40%26%25%22%30%26%

16 Stats and Stuff

17 17 Total Continuation Filing Rates *Straight Continuations 37 CFR §1.53 (b)(1) – No Divisionals or CIPs – as of 10/23/05

18 18 Distribution of Independent Claims at Filing

19 19 Distribution of Total Claims at Filing

20 20 Total Claims at Filing and Issue

21 21 Distribution of the Number of References Cited in Applications

22 Pendency Projections

23 HistoricWithout Strategic Plan

24 HistoricWithout Strategic Plan 1,000 Hires & Low Attrits

25 HistoricWithout Strategic Plan 1,000 Hires & Low AttritsPlus Claims & Continuation Limits

26 HistoricWithout Strategic Plan1,000 Hires & Low AttritsPlus Claims & Continuation LimitsPlus Patentability Report

27

28 Production You Can’t Hire Your Way Out of This One

29 29

30 Markush Practice

31 31 1.A cell adhesion protein of formula (1), A-(B)-(C)-(D) n -E or a pharmaceutically acceptable derivative thereof, wherein...

32 Accelerated Examination Would You Like Your Patent In 12 Months ?!?

33 33 Accelerated Examination Features of the proposed revision: Features of the proposed revision:  Move to the head of the line  Final Disposition within 12 months  Program for expedited Issuance of Patents  e-file application and all follow on papers  Single Invention  Limited Number of Claims  Patentability Report  Possible Interview before 1 st Action  Shortened Statutory Period  Enforcement of special status in the Corps

34 34 Contact Information Joseph Rolla Deputy Commissioner for Patent Examination Policy e-mail:joseph.rolla@uspto.govjoseph.rolla@uspto.gov Phone: 571 272 8800


Download ppt "Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy."

Similar presentations


Ads by Google